Zachary Contreras from Sharp Health Plan explains how managed care organizations can support early adoption of DM-BUP to ...

While limited data suggest loncastuximab tesirine plus rituximab may be active in the third line, larger cohorts and ...

Nerandomilast, a PDE4B inhibitor, is a new treatment option for IPF, showing better tolerability than nintedanib and ...

Zachary Contreras from Sharp Health Plan discusses findings from the AMCP Nexus study showing that dextromethorphan-bupropion ...

Many adults with obstructive hypertrophic cardiomyopathy (oHCM) taking mavacamten experienced new atrial fibrillation or flutter, new-onset heart failure, and frequent acute care use within months of ...

Experts discuss the clinical and economic burden of idiopathic pulmonary fibrosis (IPF), emerging clinical data, and ...

Secondary cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves overall survival in ...

Nevada’s rapidly growing patient population is straining cardiovascular care capacity, leaving many patients without timely ...

Advances in CAR T-cell therapy and bispecific antibodies have expanded treatment options, though access challenges remain. Medicaid expansion has enhanced cancer care in Louisiana, boosting access to ...

Clonal hematopoiesis of indeterminate potential (CHIP) subtypes, specifically non- DNMT3A genes, were associated with incident heart failure in older patients in a recent study published in JAMA ...

Osteoarthritis is more strongly associated with urge urinary incontinence, while rheumatoid arthritis is more linked to stress urinary incontinence. US adults with arthritis have higher odds of stress ...

Veterans in socioeconomically vulnerable areas and those experiencing homelessness face higher mortality risks during EHEs.